Compare Sogroya vs. Omnitrope
Head-to-head comparisons of medication uses, side effects, warnings, and more.
- Sogroya (somapacitan)Omnitrope (somatropin)
- Sogroya (somapacitan)Omnitrope (somatropin)
Summary of Sogroya vs. Omnitrope
Summary for Recombinant human growth hormonePrescription onlySogroya (somapacitan or somapacitan-beco) is a long-acting growth hormone injection used to treat low growth hormone in adults and children age 2.5 years and older. It's also FDA approved for children with certain growth-related conditions, like Noonan syndrome and Idiopathic short stature. Sogroya (somapacitan) comes as a pre-filled pen that's injected under the skin once a week. Common side effects include headache, fever, and back pain.
Summary for Recombinant human growth hormonePrescription onlyOmnitrope (somatropin) is a growth hormone therapy used to treat adults and children with low growth hormone. It's also used in children with certain conditions that affect growth, like Prader-Willi syndrome and Turner syndrome. The medication is given as an injection under the skin, usually once a day. Some side effects include headache, swelling, and joint pain.
Indications of Sogroya vs. Omnitrope
Indications for•Growth problems caused by certain conditions in children age 2.5 years and older (e.g., low growth hormone, small for gestational age, Noonan syndrome, idiopathic short stature)•Low growth hormone in adultsIndications for•Growth problems caused by certain conditions in children (e.g., low growth hormone, Prader-Willi syndrome, small for gestational age, Turner syndrome, idiopathic short stature)•Low growth hormone in adultsPros and Cons of Sogroya vs. Omnitrope
Pros and Const for Recombinant human growth hormonePros•Longer-acting so you only need to inject once a week•Safe for children and adults•Comes as a ready-to-use penCons•Requires regular monitoring•Can cause swelling and joint pain•Might raise blood sugarPros and Const for Recombinant human growth hormonePros•Approved for many growth-related conditions in children•Safe for children and adults•Comes in a vial or pre-mixed penCons•Typically injected every day•Requires regular monitoring•Can cause injection site reactions and joint painCommon Side Effects of Sogroya vs. Omnitrope
Common Side Effects forChildren (treatment of low growth hormone)
•Common cold symptoms (17%)•Headache (12%)•Pain in the arms and legs (10%)•Fever (9%)•Injection site reaction (6%)•Diarrhea (5%)•Nausea or vomiting (5%)Adults
•Back pain (10%)•Joint pain (7%)•Indigestion (5%)Common Side Effects forChildren
•Bruising (9%)•Headache (7%)•Leg pain (5%)Adults*
•Swelling in the arms and legs (2-18%)•Joint pain (3-17%)•Upper respiratory infections (13-16%)•Pain in the arms and legs (2-15%)*Adult data comes from a study where a similar growth hormone medication was used.
Warnings of Sogroya vs. Omnitrope
Common Side Effects for•Higher risk of death during serious illness•Severe allergic reactions•New or returning tumors•High blood sugar•High pressure in the brain•Swelling in the body•Low hormone levels•Bone and growth changes in children•Swelling of the pancreas•Fat tissue damage•Higher risk of death in children with Prader-Willi syndromeCommon Side Effects for•Higher risk of death during serious illness•Higher risk of death in children with Prader-Willi syndrome•New or returning tumors•High blood sugar•High pressure in the brain•Severe allergic reactions•Swelling in the body•Low hormone levels•Bone and growth changes in children•Ear infections and heart problems for people with Turner Syndrome•Fat tissue damage•Swelling of the pancreas•Benzyl alcohol warning for infantsPrices with our coupons for Sogroya vs. Omnitrope
Browse medications
View AllResearch prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.